Matsuura M - Search Results

1

Identification of cancer driver mutations in liquid-based cytology samples for the screening of endometrial diseases.

Matsuura M, Takane K, Yamaguchi K, Ikenoue T, Hatakeyama S, Kurokawa S, Tamate M, Akimoto T, Iwasaki M, Sugita S, Hasegawa T, Ota Y, Saito T, Furukawa Y. Matsuura M, et al. BJC Rep. 2023 Nov 2;1(1):18. doi: 10.1038/s44276-023-00020-y. BJC Rep. 2023. PMID: 39516270 Free PMC article.

2

Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer.

Suzuki T, Morishita M, Ito E, Matsuura M, Tanaka R, Saito T. Suzuki T, et al. Among authors: matsuura m. Am J Ther. 2008 Jan-Feb;15(1):31-5. doi: 10.1097/01.MJT.0000249928.97210.29. Am J Ther. 2008. PMID: 18223351 Clinical Trial.

3

Chemotherapy (CT) with radiotherapy versus CT alone for FIGO Stage IIIc endometrial cancer.

Matsuura M, Suzuki T, Morishita M, Tanaka R, Ito E, Saito T. Matsuura M, et al. Eur J Gynaecol Oncol. 2009;30(1):40-4. Eur J Gynaecol Oncol. 2009. PMID: 19317255

4

Osteopontin is a new target molecule for ovarian clear cell carcinoma therapy.

Matsuura M, Suzuki T, Saito T. Matsuura M, et al. Cancer Sci. 2010 Aug;101(8):1828-33. doi: 10.1111/j.1349-7006.2010.01615.x. Epub 2010 May 12. Cancer Sci. 2010. PMID: 20545695 Free PMC article.

5

Prediction of histologic type and lymph node metastasis for advanced ovarian cancer on uterine cervical and endometrial cytology.

Suzuki M, Suzuki T, Matsuura M, Iwasaki M, Tanaka R, Ito E, Fujii M, Saito T. Suzuki M, et al. Among authors: matsuura m. Acta Cytol. 2010 Jul-Aug;54(4):575-81. doi: 10.1159/000325180. Acta Cytol. 2010. PMID: 20715659

6

Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma.

Matsuura M, Suzuki T, Suzuki M, Tanaka R, Ito E, Saito T. Matsuura M, et al. Oncol Rep. 2011 Jan;25(1):41-7. Oncol Rep. 2011. PMID: 21109955

7

Evaluation of cervical conization as a definitive treatment for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3.

Takeda N, Suzuki T, Suzuki M, Matsuura M, Tanaka R, Fujii M, Ito E, Saito T. Takeda N, et al. Among authors: matsuura m. Arch Gynecol Obstet. 2012 Feb;285(2):453-7. doi: 10.1007/s00404-011-1944-4. Epub 2011 Jun 17. Arch Gynecol Obstet. 2012. PMID: 21681515

8

Low-dose SN-38 with paclitaxel induces lethality in human uterine cervical adenocarcinoma cells by increasing caspase activity.

Teramoto M, Suzuki T, Satohisa S, Akashi Y, Matsuura M, Suzuki M, Tanaka R, Saito T. Teramoto M, et al. Among authors: matsuura m. Med Mol Morphol. 2014 Mar;47(1):31-7. doi: 10.1007/s00795-013-0036-x. Epub 2013 Mar 16. Med Mol Morphol. 2014. PMID: 23504048

9

Prediction of the therapeutic effect of dienogest in ovarian endometrial cysts using the apparent diffusion coefficient.

Matsuura M, Tamate M, Tabuchi Y, Takada S, Tanaka R, Iwasaki M, Saito T. Matsuura M, et al. Gynecol Endocrinol. 2014 Aug;30(8):597-9. doi: 10.3109/09513590.2014.911277. Epub 2014 May 8. Gynecol Endocrinol. 2014. PMID: 24811093 Free article.

10

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following paclitaxel and carboplatin in patients with gynecologic cancers: A randomized, multicenter, phase-II trial.

Matsuura M, Satohisa S, Teramoto M, Tanaka R, Iwasaki M, Nishikawa A, Mizunuma M, Tanaka S, Hayakawa O, Saito T. Matsuura M, et al. J Obstet Gynaecol Res. 2015 Oct;41(10):1607-13. doi: 10.1111/jog.12748. Epub 2015 Jul 21. J Obstet Gynaecol Res. 2015. PMID: 26199182 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,192 results

Search Page

Filters